Sign In
Buy COLL
$31.06
+0.580 (+1.90%)
At Close: Jun 03, 2026
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shares Sold by Bank of America Corp DE
08:36am, Saturday, 02'nd May 2020
Bank of America Corp DE lowered its stake in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) by 57.0% during the fourth quarter, according to the company in its most recent disclosure with the Se
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX), Biogen (BIIB) and Emergent Biosolutions
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX – Research
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Dynavax (DVAX)
03:50pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (BMRN) and Dynavax (DVAX) with
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Dynavax (NASDAQ: DVAX)
03:50pm, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (
BMRN
–
Research Report
) and Dynavax (
DVAX
–
Research Report
) with bull
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:18pm, Friday, 01'st May 2020
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:18pm, Friday, 01'st May 2020
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report) today and set a price
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04:34pm, Thursday, 30'th Apr 2020
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04:34pm, Thursday, 30'th Apr 2020
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Collegium Pharmaceutical (COLL) to Release Earnings on Thursday
09:48am, Thursday, 30'th Apr 2020
Collegium Pharmaceutical (NASDAQ:COLL) is set to announce its earnings results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.32 per share for the
Top-Level industry professionals to speak at Pain Therapeutics Conference in 2 weeks
03:20pm, Monday, 27'th Apr 2020
2 weeks Pain Therapeutics Conference - expert speakers
Needham Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
01:32pm, Monday, 27'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on Amphastar Pharmaceuticals (AMPH). The company's shares closed last
Needham Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
01:32pm, Monday, 27'th Apr 2020
In a report released today,
Serge Belanger
from Needham maintained a
Hold
rating on Amphastar Pharmaceuticals (
AMPH
–
Research Report
). The company’s shares closed last Monday at $17.10.
Accordi
Collegium Pharmaceutical Inc (NASDAQ:COLL) Receives Average Recommendation of "Buy" from Brokerages
10:42am, Monday, 27'th Apr 2020
Collegium Pharmaceutical Inc (NASDAQ:COLL) has received an average recommendation of “Buy” from the ten ratings firms that are currently covering the firm, MarketBeat reports. Four equities resear
Collegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated at Needham & Company LLC
05:08am, Sunday, 26'th Apr 2020
Investment analysts at Needham & Company LLC started coverage on shares of Collegium Pharmaceutical (NASDAQ:COLL) in a research report issued to clients and investors on Friday, TipRanks reports. The
